Abstract: The present invention is directed to methods and compositions for increasing a growth characteristic of a plant, increasing nutrient use efficiency of a plant, or improving a plant’s ability to overcome biotic or abiotic stress comprising applying a composition comprising mixed linked ?-1,3/?-1,4 glucans (MLGs) to a plant, plant part, propagation material of the plant, or to the soil, hydroponic solution or growth media in which a target plant is growing.

Abstract: The present invention is directed to methods and compositions for increasing a growth characteristic of a plant, increasing nutrient use efficiency of a plant, or improving a plant's ability to overcome biotic or abiotic stress comprising applying a composition comprising a fungal mycelia extract comprising piperidine and/or an analogue thereof (e.g., 6-oxopiperidine-2-carboxylic acid) and/or a salt thereof (e.g., 6-oxopiperidine-2-carboxylate), or any combination thereof to a plant, plant part, or to a propagation material of the plant.

Abstract: The invention relates to a plant having increased resistance to pathogens, wherein the protein SOBIR1 from Arabidopsis thaliana or a homologous protein, which is capable of interacting with at least one of the PRR receptor proteins RLP30 or RLP1, and at least one of the PRR receptor proteins RLP30 or RLP1 are overexpressed in comparison with the wild-type plant or are newly synthesized. The pathogens are preferably fungi, in particular from the genus Sclerotinia, and bacteria, in particular from the genus Xanthomonas. The invention further relates to a method for producing a plant having increased resistance to pathogens.

Abstract: The invention relates to a plant having increased resistance to pathogens, wherein the protein SOBIR1 from Arabidopsis thaliana or a homologous protein, which is capable of interacting with at least one of the PRR receptor proteins RLP30 or RLP1, and at least one of the PRR receptor proteins RLP30 or RLP1 are overexpressed in comparison with the wild-type plant or are newly synthesized. The pathogens are preferably fungi, in particular from the genus Sclerotinia, and bacteria, in particular from the genus Xanthomonas. The invention further relates to a method for producing a plant having increased resistance to pathogens.

Abstract: This method for changing the radio access point associated with a terminal, within a Wi-Fi-DECT wireless telecommunication network comprising dual-mode Wi-Fi-DECT radio terminals (PP) and Wi-Fi-DECT radio access points (AP1, AP2) connected to a local area network; comprises a step consisting of changing the Wi-Fi-DECT radio access point for the Wi-Fi part of the terminal in question (PP) whenever it is decided to change the Wi-Fi-DECT radio access point for the DECT part of the terminal in question (PP).

Abstract: The present invention relates to a purified fungal extract (SsE1) that elicits immune responses in plants and the identification of the plant receptor AtRLP30 which mediates the recognition of SsE1. Further provided are methods for the production of the extract SsE1, and the use of the SsE1 and AtRLP30 in plants in order to modulate the plants immune response, in particular against fungal infections with Sclerotinia spp. or Botrytis spp.

Abstract: This method for changing the radio access point associated with a terminal, within a Wi-Fi-DECT wireless telecommunication network comprising dual-mode Wi-Fi-DECT radio terminals (PP) and Wi-Fi-DECT radio access points (AP1, AP2) connected to a local area network; comprises a step consisting of changing the Wi-Fi-DECT radio access point for the Wi-Fi part of the terminal in question (PP) whenever it is decided to change the Wi-Fi-DECT radio access point for the DECT part of the terminal in question (PP).

Abstract: The crystalline form of 2-(4,6-bis-biphenyl-4-yl-1,3,5-triazin-2-yl)-5-(2-ethyl-(n)-hexyloxy)phenol, characterized by a melting range of 118-126° C.

Abstract: The crystalline form of 2-(4,6-bis-biphenyl-4-yl-1,3,5-triazin-2-yl)-5-(2-ethyl-(n)-hexyloxy)phenol, characterized by a melting range of 118-126° C.

Abstract: The crystalline form of 2-(4,6-bis-biphenyl-4-yl-1,3,5-triazin-2-yl)-5-(2-ethyl-(n)-hexyloxy)phenol, characterized by a X-ray diffraction pattern obtained by using Cu—K?-radiation which exhibits the diffraction angles (2-Theta).

Abstract: The crystalline form of 2-(4,6-bis-biphenyl-4-yl-1,3,5-triazin-2-yl)-5-(2-ethyl-(n)-hexyloxy)phenol, characterized by a X-ray diffraction pattern obtained by using Cu—K?-radiation which exhibits the diffraction angles (2-Theta).

Abstract: Compounds of Formula (1), wherein R1 is hydrogen; C1-C18alkyl; trifluoromethyl; C3-C8cycloalkyl; phenylC1-C5alkyl; phenyl-C1-C5alkoxy; mono- or di-N-C1-C5alkamino-C1-C5alkyl; amino-di-N-C1-C5alkylamino-C1-C5alkyl; C1-C5alkoxy-C1-C5alkyl; R2 is C2-C20alkyl; hydroxy-C1-C20alkyl; phenyl; phenyl-C1-C5alkyl; phenyl-C1-C5alkoxy; mono- or di-N-C1-C5alkylamino-C1-C5alkyl; amino-di-N-C1-C5alkylamino-C1-C5alkyl; or heteroaryl-C1-C5alkyl; or R1 and R2 together with the nitrogen atom bonding them form a 5- to 7-membered monocyclic heterocyclic ring; are described. They are suitable for the antimicrobial treatment of surfaces, especially as antimicrobial active ingredients against gram-positive and gram-negative bacteria.

Abstract: The present invention relates to a process for the preparation of compounds of formula (1), in which R1, R2 and R3 independently of one another are hydrogen, halogen , trifluoromethyl of or C1-C4alkoxy, wherein a compound of formula (2), in which R1, R2 and R3 are as defined in formula (1), is reacted with methlyamine in the presence of a non-alcoholic solvent and, if desired, in the presence of a sulfonic acid catalyst to give the compound of formula (2) and, if desired, is subject to purification by recrystallization.

Abstract: Described is a process for the preparation of compounds of formula (1a) which comprises reacting an isomeric mixture consisting of from 75 to 95% of compound of formula (2a) and from 5 to 25% of a compound of formula (2b) with methylamine, in a suitable solvent, to form a sertraline-imine isomeric mixture consisting of from 75 to 95% of formula (1a) and from 5 to 25% of formula (1b)(A1), or reacting an isomeric mixture consisting of from 75 to 95% of a compound of formula (2a) and from 5 to 25% of a compound of formula (2b) with methylamine, in a suitable solvent, using suitable methods of isolation to form an enriched sertraline-imine isomeric mixture, consisting of >99% of a compound of formula (1a) and <1% of a compound of formula (1b)(A2); and then subjecting the sertraline-imine isomeric mixture obtained according to reaction route (A1) or (A2), in a suitable solvent, to recrystallisation (B), in accordance with scheme (I) wherein in formula (1a), R1, R2 and R3 are each independently of the others

Abstract: A process is described for preparing diphenylamines of the formula ##STR1## by oxybromination of a phenol ether compound using elemental bromine in the presence of hydrogen peroxide and of a catalyst to give a brominated phenol ether compound which is subsequently reacted with a formanilide compound to give the compound of the formula (1).The oxybromination reaction is a regioselective, environmentally friendly and cost-efffective method of preparing brominated aromatic compounds.The diphenylamines of the formula (1) are industrially useful intermediates for the production, for example of dyes, and in particular of color formers of the fluoran type for pressure- or heat-sensitive recording systems.